We are live on ! Find out more
KWM

Kingsview Wealth Management Portfolio holdings

AUM $7.33B
1-Year Est. Return 16.07%
This Fund
S&P 500
This Quarter Est. Return
+10.29%
1 Year Est. Return
+16.07%
3 Year Est. Return
+55.85%
5 Year Est. Return
+68.48%
10 Year Est. Return
–
AUM
$3.35B
AUM Growth
+$566M
Cap. Flow
+$280M
Cap. Flow %
8.37%
Top 10 Hldgs %
21.55%
Holding
1,038
New
110
Increased
358
Reduced
438
Closed
94

Top Buys

Rank Stock Value
1
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$25.5M
2
MPRO icon
Monarch ProCap Index ETF
MPRO
+$21.8M
3
MBCE
Monarch Blue Chips Elite Index ETF
MBCE
+$17.1M
4
COST icon
Costco
COST
+$16.5M
5
MRK icon
Merck
MRK
+$16.3M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$14.2M
2
NEE icon
NextEra Energy
NEE
+$10.7M
3
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$8.22M
4
MLKN icon
MillerKnoll
MLKN
+$7.54M
5
CE icon
Celanese
CE
+$4.78M

Sector Composition

Rank Sector Weight
1 Technology 13.63%
2 Consumer Discretionary 6.67%
3 Healthcare 6.18%
4 Financials 6.16%
5 Industrials 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETW
926
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.05B
$114K ﹤0.01%
14,638
-94
-0.6% -$711
ECC
927
Eagle Point Credit Company
ECC
$510M
$113K ﹤0.01%
11,900
– –
BOE icon
928
BlackRock Enhanced Global Dividend Trust
BOE
$684M
$107K ﹤0.01%
10,814
-4,000
-27% -$38.4K
FEI
929
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$104K ﹤0.01%
12,190
– –
ESPR
930
DELISTED
Esperion Therapeutics
ESPR
$94.2K ﹤0.01%
+31,500
New +$40.9K
HLN icon
931
Haleon
HLN
$43.8B
$88K ﹤0.01%
10,696
-7,272
-40% -$59.9K
ZVRA icon
932
Zevra Therapeutics
ZVRA
$622M
$79.4K ﹤0.01%
12,120
– –
KSCP icon
933
Knightscope
KSCP
$27.1M
$74.9K ﹤0.01%
2,498
+612
+32% +$21.4K
APYX icon
934
Apyx Medical
APYX
$174M
$31.7K ﹤0.01%
+12,085
New +$29.3K
NGD
935
DELISTED
New Gold Inc
NGD
$25.8K ﹤0.01%
17,650
+2,650
+18% +$3.33K
PYXS icon
936
Pyxis Oncology
PYXS
$198M
$19.3K ﹤0.01%
10,707
– –
URG
937
Ur-Energy
URG
$517M
$16.9K ﹤0.01%
11,000
– –
ONCY
938
Oncolytics Biotech
ONCY
$95.1M
$14.8K ﹤0.01%
+11,000
New +$17.2K
REFR icon
939
Research Frontiers
REFR
$16.5M
$14.5K ﹤0.01%
14,366
-360
-2% -$374
PMN icon
940
ProMIS Neurosciences
PMN
$121M
$12.8K ﹤0.01%
+444
New +$16.6K
GNPX icon
941
Genprex
GNPX
$2.24M
– –
0
– –
GOEV
942
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$2.83K ﹤0.01%
24
+2
+9% +$271
ACB
943
CALL
Aurora Cannabis
ACB
$180M
$653 ﹤0.01%
+1,100
New +$5.3K
BETS
944
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
$535 ﹤0.01%
+50
New +$8.33K
ABG icon
945
Asbury Automotive
ABG
$3.94B
– –
-1,219
Closed -$280K
AFG icon
946
American Financial Group
AFG
$12.2B
– –
-19,155
Closed -$2.14M
AIZ icon
947
Assurant
AIZ
$14.9B
– –
-16,143
Closed -$2.32M
ARKF icon
948
ARK Blockchain & Fintech Innovation ETF
ARKF
$760M
– –
-63,735
Closed -$1.23M
ARKQ icon
949
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.01B
– –
-25,273
Closed -$1.33M
AVAV icon
950
AeroVironment
AVAV
$8.51B
– –
-6,610
Closed -$737K
36 37
38
39 40

Similar funds

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return

Kingsview Wealth Management's Q4 2023 Portfolio in Review

As of Q4 2023, Kingsview Wealth Management held 1,038 positions worth $3.35B, up 20% from $2.78B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Kingsview Wealth Management deployed $280M of net new capital in Q4 2023, opening 110 new positions and adding to 358 existing holdings. Its largest new stake was First Trust Intermediate Government Opportunities ETF: 645,026 shares worth $13.2M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Walt Disney, an estimated $14.2M trimmed.

  • Kingsview Wealth Management's largest Q4 2023 buy was First Trust Intermediate Government Opportunities ETF: 645,026 shares worth $13.2M.
  • Kingsview Wealth Management added most to iShares Core S&P Total US Stock Market ETF in Q4 2023, an estimated $25.5M increase.
  • Kingsview Wealth Management's biggest Q4 2023 reduction was Walt Disney, cutting an estimated $14.2M.
  • Kingsview Wealth Management fully exited Lazard in Q4 2023, selling an estimated $3.03M.
  • Kingsview Wealth Management's ten largest holdings make up 22% of its $3.35B portfolio in Q4 2023.
  • Kingsview Wealth Management opened 110 new positions and closed 94 in Q4 2023.
  • Kingsview Wealth Management's portfolio value rose 20% quarter-over-quarter to $3.35B.

Based on Kingsview Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.